009290 — Kwangdong Pharmaceutical Share News
0.000.00%
- KR₩326bn
- KR₩519bn
- KR₩2tn
Brief: Kwangdong Pharmaceutical To Divest 25 Billion Won Worth Of Own Shares
Brief: Kwangdong Pharmaceutical To Divest 22 Billion Won Worth Of Own Shares
Ocugen up after licensing deal for ophthalmic gene therapy in South Korea
Brief: Kwangdong Pharmaceutical Q1 Operating Profit 3.3 Billion Won, Down 80.6% From Year Earlier
Brief: Kwangdong Pharmaceutical Q4 Operating Profit 6.7 Billion Won, Up 104.5% From Year Earlier
Brief: Kwangdong Pharmaceutical Q3 Operating Profit 1.4 Billion Won, Down 87.6% From Year Earlier
Brief: Kwangdong Pharmaceutical Q2 Consolidated Operating Profit 5 Billion Won, Down 57.7% From Year Earlier
Brief: Kwangdong Pharmaceutical To Acquire 17 Billion Won Worth Of Shares In Precision Biosensor Inc
Brief: Kwangdong Pharmaceutical Q1 Operating Profit 17 Billion Won, Up 7.7% From Year Earlier
Brief: Kwangdong Pharmaceutical Acquiring 30 Billion Won Worth Of Shares In Bl Healthcare Corp
Brief: Kwangdong Pharmaceutical Q3 Operating Profit 11 Billion Won, Up 43% From Year Earlier
Brief: Kwangdong Pharmaceutical Q2 Operating Profit 12 Billion Won, Up 15.7% From Year Earlier
Brief: Kwangdong Pharmaceutical To Halt Production At Food Factory Due To Fire
Brief: Kwangdong Pharmaceutical Says To Buy Back 7 Bln Won Worth Of Shares
Brief: Palatin Technologies signs licensing agreement with Kwangdong Pharma
Brief: Kwangdong Pharmaceutical sees FY 2017 revenue to be 743.2 bln won